4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-25-022551
Chief Financial Officer sold 9,522 shares at an average $3.53 ($33,649)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NOUGUES MAXIMO F Chief Financial Officer | 2025-07-08 | Sale 10b5-1 | −5,587 | $3.53 | $19,739 | 208,164 | D |
| NOUGUES MAXIMO F Chief Financial Officer | 2025-07-09 | Sale 10b5-1 | −3,935 | $3.54 | $13,910 | 204,229 | D |
| Open-market sales · 9,522 sh · avg $3.53 · $33,649 | |||||||
Loading xslF345X05/rdgdoc.xml…